Kei Nakagawa

13PUBLICATIONS
26CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Applied theatreSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 19, 2026
Significance of next-generation sequencing in the era of targeted therapy for biliary tract cancer: an analysis at a single institution.

|May 13, 2026
Suture Versus Non-Suture Closure of the Cystic Duct Orifice During Fenestrating Laparoscopic Subtotal Cholecystectomy: A Single-Center Retrospective Study.

|Jan 09, 2026
Retroperitoneal Dedifferentiated Liposarcoma With Penetrating Abscess Formation Secondary to Ileal Invasion: A Case Report.

Kenichiro Yambe, Kei Nakagawa, Kuniharu Yamamoto

|Sep 12, 2025
Fecal colitis obliterans and cytomegalovirus enteritis after pancreaticoduodenectomy for resectable pancreatic cancer.

Kei Nakagawa, Kazuhiro Takami, Hiroto Sakurai

|Feb 14, 2025
High preoperative Glasgow prognostic score increases a risk of hospital mortality in elderly patients with perihilar cholangiocarcinoma.

Takashi Kokumai, Shuichi Aoki, Kei Nakagawa

|Oct 08, 2024
Usefulness of multigene liquid biopsy of bile for identifying driver genes of biliary duct cancers.

Shin Ito, Mika Ando, Shuichi Aoki

Pageof 3

Frequent Collaborators

8 joint publications

Michiaki Unno

5 joint publications

Tatsuo Hata

4 joint publications

Masamichi Mizuma

4 joint publications

Takanori Morikawa